Primary Record
Tadalafil
- In stock
- 4,832 g
- Purity
- 99.7 %
- CAS
- 171596-29-5
Compound Identifiers & Properties
- CAS
- 171596-29-5
- PubChem CID
- 110635
- SMILES
- CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
- Canonical SMILES
- CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O
Names & Synonyms
- Tadalafil
- Cialis
- 171596-29-5
- Tadanafil
- ADCIRCA
- Tadalafilo
- Ic351
- Tadalafil mylan
- Trans-tadalafil
- zalutia
- Tadalafil Lilly
- Tadalafil [USAN]
- tadalafilum
- tardenafil
- Tadalafila
- Acdirca
- Tadalafil bulk
- Tadalafil(Cialis)
- Tadalafil?
- CHEWTADZY
- Tadalafil API
- Tadalafil CRS
- Tadalafil USP
- Tadalafil solution
- 1xoz
- Cialis (TN)
- Cialis, Tadalafil
- Tadalafil anhydrous
- Adcirca (TN)
- Tadalafil (Cialis)
- Tadalafil(Cialis)/
- Zalutia (TN)
- ICOS 351
- Tadalafil raw powder
- IC 351
- IC-351
- Tardenafil|||Cialis
- ALYQ
- TADLIQ
- TILDENAFIL
- Tadalafil (Standard)
- Lilly brand of tadalafil
- 742SXX0ICT
- RefChem:6280
- CHEMBL779
- TADALAFIL [INN]
- TADALAFIL [JAN]
- UNII-742SXX0ICT
- TADALAFIL [MI]
- TADALAFIL; CIALIS
- TADALAFIL [HSDB]
- TADALAFIL [VANDF]
- (-)-Tadalafil (6R)
- DTXSID9046786
- Tadalafil [USAN:INN:BAN]
- D05MQK
- TADALAFIL [MART.]
- HSDB 7303
- TADALAFIL [USP-RS]
- TADALAFIL [WHO-DD]
- C22H19N3O4
- Tadalafil (JAN/USP/INN)
- MFCD07771966
- SCHEMBL33333
- DTXCID7026786
- TADALAFIL [EMA EPAR]
- CHEBI:71940
- GF 196960
- MLS000759426
- MLS001165782
- MLS001195644
- MLS001424132
- MLS006010126
- Tadalafil (JAN/USAN/INN)
- NSC-750236
- NSC-759172
- Tadalafil - Bio-X trade mark
- ENTADFI COMPONENT TADALAFIL
- OPSYNVI COMPONENT TADALAFIL
- WOXKDUGGOYFFRN-IIBYNOLFSA-N
- AC1L380B
- GTPL7299
- orb1308738
- PYR280
- TADALAFIL [ORANGE BOOK]
- SCHEMBL29358190
- SCHEMBL29427554
- TADALAFIL [EP MONOGRAPH]
- BDBM14777
- CTK8B6705
- ERK5-3B15
- (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione
- G04BE08
- LY-450190
- TADALAFIL [USP MONOGRAPH]
- Tadalafil CRS (Y0001417)
- GLXC-07318
- HMS2051N17
- HMS2235L21
- HMS3884G19
- HY-90009AR
- LY450190
- Pharmakon1600-01505639
- AMY10321
- EX-A2644
- KS-1117
- MSK10246
- ZINC3993855
- GF-196960
- Tox21_112642
- ABP000527
- ANW-54093
- CC0257
- CID110635
- EBC-09118
- HY-90009A
- NP3496
- NSC750236
- NSC759172
- s1512
- Tadalafil 1.0 mg/ml in Acetonitrile
- AKOS015892559
- C22-H19-N3-O4
- Tox21_112642_1
- AB42193
- ACN-028821
- CCG-100973
- CID:110635
- CS-1414
- DB00820
- FB02802
- NC00223
- NSC 750236
- NSC 759172
- RTR-007551
- 1,3-benzodioxol-5-yl(methyl)[?]dione
- NCGC00168781-01
- NCGC00263909-02
- Tadalafil 100 microg/mL in Acetonitrile
- AN-15538
- BT164435
- CPD000466321
- GF196960
- SAM001246586
- SC-16083
- SMR000466321
- SID:283537496
- AB0008473
- AB1009208
- LS-186558
- LS-187015
- LS-187770
- A4327
- CAS-171596-29-5
- NS00006532
- SW197603-2
- J1.662.659G
- A23556
- D02008
- J90025
- W-5349
- X-3024
- (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
- (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
- AB00639969-08
- AB00639969_09
- AB00639969_10
- 596T295
- AR-270/43507798
- C429886
- Q424156
- SR-05000001940
- (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
- A1199462
- SR-05000001940-1
- BRD-K93645900-001-04-8
- BRD-K93645900-001-11-3
- BRD-K93645900-001-12-1
- (6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
- Cialis, GF 196960, IC 351, ICOS 351, Tadalafil
- D000068581
- Z1501485354
- (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
- 6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE
- Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-
- Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R-trans)-
- (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
- CIA
- Pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-
- Tadalafil solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material
- (1R)-N-Methyl-N,2-(2-oxoethane-1,2-diyl)-1beta-(1,3-benzodioxole-5-yl)-1,2,3,4-tetrahydro-beta-carboline-3beta-carboxamide
- (2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo(8.7.0.0^(3,8).0^(11,16))heptadeca-1(10),11,13,15-tetraene-4,7-dione
- (2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11(16),12,14-tetraene-4,7-dione
- (2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11,13,15-tetraene-4,7-dione
- (2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
- (5aR,10R)-5a,6,7,8,9,9a,10,11-Octahydro-7-methyl-10-(1,3-benzodioxole-6-yl)-7,9a,11-triaza-5H-benzo[b]fluorene-6,9-dione
- (6R,12 aR)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,12?R)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12?-tetrahydropyrazino[1',2':1,6]pyrido[3,4-?]indole-1,4(6H,7H)-dione
- (6R,12aR) 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino [1',2':1,6] pyrido[3,4-b]indole-1,4-dione
- (6R,12aR) 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione; (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione; (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione; (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino [1',2':1,6]pyrido[3,4-b]indole-1,4-dione; Cialis; GF 196960; IC 351; ICOS 351; Tadalafil; Tildenafil; UK 336017
- (6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1,2:1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1,2,1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,12aR)-6-(1,3-Benzodioxole-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1 ,2 :1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,12aR)-6-(2H-1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,12aR)-6alpha-(1,3-Benzodioxole-5-yl)-2,3,6,7,12,12abeta-hexahydro-2-methylpyrazino[1 ,2 :1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,3,6,7,12,12a-Hexahydro-2-methyl-6-[3,4-(methylenedioxy)phenyl]pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
- 1242099-07-5
- 171488-03-2
- 171596-27-3
- 6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione
- Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-
- Pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R-trans)-
- Pyrazino[1',6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12ahexahydro-2-methyl-, (6R,12aR)-
- rel-(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione